BioPharma Pharma & Biopharma Manufacturing
Harbour BioMed scientists and Dana-Farber researchers will be working together to develop novel oncologic drugs, including bispecific antibodies and CAR-T ...
June 16, 2021 | News
Sermo, the world’s leading HCP insights company and the first social media platform for physicians, today announced its acquisition of Australia-base...
June 15, 2021 | News
What is tech transfer, and when does it happen? Technology transfer is a formalized process for moving the manufacture of a drug from one facility, one sc...
June 14, 2021 | Analysis
By combining Ritter's liquid dispensing platform for clinical diagnostic testing and life sciences research with Avantor's offerings for critical lab autom...
June 12, 2021 | News
NMN is a natural compound found in the human body and is constantly being metabolized. It is also found in trace amounts in certain foods. NMN serves as a ...
June 10, 2021 | News
New Multi Reflecting Time-of-Flight (MRT) mass spectrometry platform from Waters delivers highest quality resolution at fast speedsi. Exceptional clarit...
June 09, 2021 | News
New lab will support Singapore government’s Industry 4.0 agenda to build research, digital, innovation capability and talent development Part of C...
June 08, 2021 | News
By leveraging the proprietary technology platform built for drug discovery and screening, MicuRx R&D team discovered the next-generation oxazolidinone ...
June 04, 2021 | News
GoSilico's software creates “digital twins” of downstream processes and is increasingly used to enhance process development by simulation Mo...
June 02, 2021 | News
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has entered i...
June 02, 2021 | News
Changzhou, China operations become Avantor's first single-use production facility in AMEA region; doubles Avantor's global single-use cleanroom space- Adds...
June 02, 2021 | News
Vancouver, Canada-based Precision NanoSystems (PNI) provides technology solutions enabling the development and manufacturing of lipid nanoparticles fo...
June 01, 2021 | News
Novartis has also decided on early termination of the RAPTOR and RAVEN studies, which assessed the efficacy and safety of brolucizumab in retinal vein occl...
May 30, 2021 | News
Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biopharmaceutical company, announced today that bas...
May 31, 2021 | News
Most Read
Bio Jobs
News